Learn More
Waters Corp Oasis Peptide Method Development 96-well µElution Plate, 2 mg Sorbent per Well, 30 µm, 1/pk
Supplier: Waters Corp 186004713
Oasis Peptide Method Development µElution Plate is designed to simplify the process of sample preparation for the analysis of therapeutic peptides in plasma. The 96-well plate format contains six rows each of two Oasis mixed-mode, ion-exchange chemistries: a strong exchanger (MAX) and a weak cation exchanger (WCX). Sample preparation method development can be quickly and easily achieved with the use of a single SPE protocol. The Oasis Peptide µElution Method Development Plate is sold separately or as a component of the UPLC Therapeutic Peptide Method Development Kit (176001835) and the HPLC Therapeutic Peptide Method Development Kit (176001836).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.